Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice
<p>Abstract</p> <p>Background</p> <p>Women with polycystic ovary syndrome (PCOS) are often treated with insulin-sensitizing agents, e.g. thiazolidinediones (TZD), which have been shown to reduce androgen levels and improved ovulatory function. Acting via peroxisome prol...
Main Authors: | Weber Mitch, Eyster Kathleen M, Brannian John D, Diggins Maureen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-03-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/6/1/10 |
Similar Items
-
Progressive obesity leads to altered ovarian gene expression in the Lethal Yellow mouse: a microarray study
by: Brannian John, et al.
Published: (2009-08-01) -
Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols
by: Bietz Mandi G, et al.
Published: (2010-03-01) -
Effect of lethal yellow (AY) mutation and photoperiod alterations on mouse behavior
by: E. Y. Bazhenova, et al.
Published: (2019-02-01) -
Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice
by: Jun Peng, et al.
Published: (2014-01-01) -
Effects of pioglitazone mediated activation of PPAR-γ on CIDEC and obesity related changes in mice.
by: Bilal Haider Shamsi, et al.
Published: (2014-01-01)